Despite that EZH2 could promote HCC development by repressing the transcription of some anti-tumor miRNAs and genes (10, 11), the global regulatory mechanisms of EZH2 in HCC were poorly understood. The gene discussed is EZH2; the disease is hepatocellular carcinoma.